According to the latest report published by Credence Research, Inc. “Neurostimulation Devices Market
(Device Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral
Nerve Stimulator, Vagus Nerve Stimulator & Gastric Electric
Stimulators; Therapeutic Areas: Pain Management, Epilepsy, Essential
Tremor, Urinary and Fecal Incontinence, Depression Dystonia,
Gastroparesis, Parkinson's Disease & Others): Growth, Future
Prospects and Competitive Analysis, 2016-2024,” the global
neurostimulation devices market was valued at US$ 4,904.9 Mn in 2015,
and is expected to reach US$ 17,017.1 Mn by 2024, expanding at a CAGR of
13.0% from 2016 to 2024.
Browse the full report Neurostimulation Devices Market - Growth, Future Prospects and Competitive Analysis, 2016-2024 at http://www.credenceresearch.com/report/neurostimulation-devices-market
Market Insights
The steady rise in demand for
neurostimulation treatment is majorly driven by growing increasing
incidence of neurological disorders worldwide, significant gap in the
outcomes of existing treatments, and growing demand for improving
quality of life, containing treatment costs and side-effects.
Neurosurgeons are increasingly seeking further efficient surgical
modalities that offer lesser treatment complexities and are minimally
invasive in nature and have longer efficacy than the conventional
treatments. This report studies the global neurostimulation devices
market based on device types, therapeutic areas and geographic
distribution.
Among the various device types, spinal
cord stimulators currently offer the most significant market potential
and the growth of this segment is driven by its growing applications in
treating chronic pain. In addition, sacral nerve stimulators is
anticipated to be the fastest progressing segment during the forecast
period due to increasing prevalence of incontinence patient base
worldwide. Deep brain stimulators are used in treatment of degenerative
disorders such as Alzheimer’s and Parkinson’s disease. These stimulators
are currently based on bourgeoning technologies and further innovation
in the nature of these systems and their treatment outcomes will offer
promising growth opportunities to this segment. Their anticipated
extension in treating conditions such as refractory epilepsy, Tourette
syndrome, cluster headache, movement dysfunctions and trigeminal
neuralgia will fuel market growth.
Pain management constitutes the largest
therapeutic area where neurostimulation devices find the widest
application. High global prevalence of pain disorders, such as chronic
pain, surgical pain and others that interfere with the quality of life
and growing adoption of neurostimulation devices on the ground of their
better therapeutic value are some of the key drivers of this segment.
Other therapeutic areas such as neurostimulation devices market for
Parkinson’s disease, epilepsy, gastric conditions are also anticipated
to undergo impressive growth rate during the forecast period on the
ground of improved treatment efficiency, rising disease prevalence in
the senescent population base and continuous product innovations.
Geographically, North America and
Western Europe together capture the largest market in 2015 and North
America is anticipated to maintain its lead throughout the forecast
period. Existence of evolved healthcare system, higher patient base and
availability of favorable reimbursement policies will remain the chief
growth drivers in North America market. On the other hand, Asia Pacific
and Latin America are expected to be the fastest progressing regional
markets during the forecast period. Prevalence of huge geriatric
population in countries such as Japan, India, China, Mexico and others
who bear a high risk and incidence of neurological and neurodegenerative
diseases and perpetual evolution of healthcare infrastructure in the
regions, along with rising awareness about management of these diseases
are the key growth drivers in Latin America and Asia Pacific markets.
Download Free Sample - http://www.credenceresearch.com/sample-request/58336
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com















